The Immunoproteasome in oxidative stress, aging, and disease

Critical Reviews in Biochemistry and Molecular Biology

Volumn 51, Issue 4, 2016, Pages 268-281

  Johnston Carey, Helen K ^a   Pomatto, Laura C D ^a   Davies, Kelvin J A ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Molecular and Computational Biology Program   (United States)

Author keywords

20S core; Adaptation; IFN ; I B ; Nrf2; proteostasis

Indexed keywords

GAMMA INTERFERON; PROTEASOME;

AGING; ANIMAL; HUMAN; IMMUNE SYSTEM; METABOLISM; OXIDATIVE STRESS; PHYSIOLOGY; PROTEINOSIS;

AGING; ANIMALS; HUMANS; IMMUNE SYSTEM; INTERFERON-GAMMA; OXIDATIVE STRESS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN AGGREGATION, PATHOLOGICAL;

EID: 84964474590     PISSN: 10409238     EISSN: 15497798     Source Type: Journal    
DOI: 10.3109/10409238.2016.1172554     Document Type: Review

References (126)

1. T.Ahtoniemi, G.Goldsteins, V.Keksa-Goldsteine,. (2007). Pyrrolidine dithiocarbamate inhibits induction of immunoproteasome and decreases survival in a rat model of amyotrophic lateral sclerosis. Mol Pharmacol 71:30–7.
2. C.T.Aiken, R.M.Kaake, X.Wang, L.Huang (2011). Oxidative stress-mediated regulation of proteasome complexes. Mol Cell Prot 10:R110.
3. M.Aki, N.Shimbara, M.Takashina,. (1994). Interferon-gamma induces different subunit organizations and functional diversity of proteasomes. J Biochem 115:257–69.
4. K.Akiyama, S.Kagawa, T.Tamura,. (1994). Replacement of proteasome subunits X and Y by LMP7 and LMP2 induced by interferon-gamma for acquirement of the functional diversity responsible for antigen processing. FEBS Lett 343:85–8.
5. A.Angeles, G.Fung, H.Luo (2012). Immune and non-immune functions of the immunoproteasome. Front Biosci 17:1904–16.
6. K.Arima, A.Kinoshita, H.Mishima,. (2011). Proteasome assembly defect due to a proteasome subunit beta type 8 (PSMB8) mutation causes the autoinflammatory disorder, Nakajo-Nishimura syndrome. Proc Natl Acad Sci USA 108:14914–19.
7. S.Bar-Nun, M.H.Glickman (2012). Proteasomal AAA-ATPases: structure and function. Biochim Biophys Acta 1823:67–82.
8. M.Basler, C.J.Kirk, M.Groettrup (2013). The immunoproteasome in antigen processing and other immunological functions. Curr Opin Immunol 25:74–80.
9. S.Beatty, H.H.Koh, M.Phil,. (2000). The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 45:115–34.
10. J.S.Beckman, M.Carson, C.D.Smith, W.H.Koppenol (1993). ALS, SOD and peroxynitrite. Nature 364:584–84.
11. F.BelardellI (1995). Role of interferons and other cytokines in the regulation of the immune response. APMIS 103:161–79.
12. A.Bierhaus, P.M.Humpert, M.Morcos,. (2005). Understanding RAGE, the receptor for advanced glycation end products. J Mol Med 83:876–86.
13. S.Bose, P.Brooks, G.Mason, A.Rivett (2001). gamma-Interferon decreases the level of 26 S proteasomes and changes the pattern of phosphorylation. Biochem J 353:291–7.
14. M.G.Brown, J.Driscoll, J.J.Monaco (1991). Structural and serological similarity of MHC-linked LMP and proteasome (multicatalytic proteinase) complexes. Nature 353:355–57.
15. A.L.Bulteau, K.C.Lundberg, K.M.Humphries,. (2001). Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion. J Biol Chem 276:30057–63.
16. D.A.Chistyakov, K.V.Savost’anov, R.I.Turakulov,. (2000). Complex association analysis of Graves disease using a set of polymorphic markers. Mol Genet Metab 70:214–18.
17. K.J.Davies (2001). Degradation of oxidized proteins by the 20S proteasome. Biochimie 83:301–10.
18. K.J.A.Davies (1993). Protein modification by oxidants and the role of proteolytic enzymes. Biochem Soc Trans 21:346–53.
19. K.J.A.Davies, A.Goldberg (1987). Proteins damaged by oxygen radicals are rapidly degraded in extracts of red blood cells. J Biol Chem 262:8227–34.
20. R.Demars, T.Spies (1992). New genes in the MHC that encode proteins for antigen processing. Trends Cell Biol 2:81–6.
21. G.Y.Deng, A.Muir, N.K.Maclaren, J.X.She (1995). Association of LMP2 and LMP7 genes within the major histocompatibility complex with insulin-dependent diabetes mellitus: population and family studies. Am J Hum Genet 56:528.
22. M.Díaz-Hernández, F.Hernández, E.Martín-Aparicio,. (2003). Neuronal induction of the immunoproteasome in Huntington’s disease. J Neurosci 23:11653–61.
23. Q.Ding, S.Martin, E.Dimayuga,. (2006). LMP2 knock-out mice have reduced proteasome activities and increased levels of oxidatively damaged proteins. Antioxid Redox Signal 8:130–5.
24. Q.Ding, K.Reinacker, E.Dimayuga,. (2003). Role of the proteasome in protein oxidation and neural viability following low-level oxidative stress. FEBS Lett 546:228–32.
25. G.Ermak, K.J.Hench, K.T.Chang,. (2009). Regulator of calcineurin (RCAN1-1L) is deficient in Huntington disease and protective against mutant huntingtin toxicity in vitro. J Biol Chem 284:11845–53.
26. G.Ermak, T.E.Morgan, K.J.A.Davies (2001). Chronic overexpression of the calcineurin inhibitory gene DSCR1 (Adapt78) is associated with Alzheimer’s disease. J Biol Chem 276:38787–94.
27. C.M.Ethen, S.A.Hussong, C.Reilly,. (2007). Transformation of the proteasome with age-related macular degeneration. FEBS Lett 581:885–90.
28. M.Evans, Y.Couch, N.Sibson, M.Turner (2013). Inflammation and neurovascular changes in amyotrophic lateral sclerosis. Mol Cell Neurosci 53:34–41.
29. J.M.Fagan, L.Waxman, A.Goldberg (1986). Red blood cells contain a pathway for the degradation of oxidant-damaged hemoglobin that does not require ATP or ubiquitin. J Biol Chem 261:5705–13.
30. B.Fellerhoff, S.Gu, B.Laumbacher,. (2011). The LMP7-K allele of the immunoproteasome exhibits reduced transcript stability and predicts high risk of colon cancer. Cancer Res 71:7145–54.
31. D.A.Ferrington, D.S.Gregerson (2012). Immunoproteasomes: structure, function, and antigen presentation. Prog Mol Biol Transl Sci 109:75–112.
32. D.A.Ferrington, A.D.Husom, L.V.Thompson (2005). Altered proteasome structure, function, and oxidation in aged muscle. FASEB J 19:644–6.
33. D.A.Ferrington, S.A.Hussong, H.Roehrich,. (2008). Immunoproteasome responds to injury in the retina and brain. J Neurochem 106:158–69.
34. G.S.Foss, H.Prydz (1999). Interferon regulatory factor 1 mediates the interferon-γ induction of the human immunoproteasome subunit multicatalytic endopeptidase complex-like 1. J Biol Chem 274:35196–202.
35. A.Fraile, A.Nieto, J.Vinasco,. (1998). Association of large molecular weight proteasome 7 gene polymorphism with ankylosing spondylitis. Arthritis Rheum 41:560–2.
36. P.Fratta, W.K.Engel, J.Mcferrin,. (2005). Proteasome inhibition and aggresome formation in sporadic inclusion-body myositis and in amyloid-β precursor protein-overexpressing cultured human muscle fibers. Am J Pathol 167:517–26.
37. K.Früh, Y.Yang, D.Arnold,. (1992). Alternative exon usage and processing of the major histocompatibility complex-encoded proteasome subunits. J Biol Chem 267:22131–40.
38. M.P.Gavilán, A.Castaño, M.Torres,. (2009). Age‐related increase in the immunoproteasome content in rat hippocampus: molecular and functional aspects. J Neurochem 108:260–72.
39. C.Giulivi, R.E.Pacifici, K.J.A.Davies (1994). Exposure of hydrophobic moieties promotes the selective degradation of hydrogen peroxide-modified hemoglobin by the multicatalytic proteinase complex, proteasome. Arch Biochem Biophys 311:329–41.
40. M.H.Glickman, A.Ciechanover (2002). The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 82:373–28.
41. M.Goedert, M.Spillantini, R.Jakes,. (1989). Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer’s disease. Neuron 3:519–26.
42. A.L.Goldberg, P.Cascio, T.Saric, K.L.Rock (2002). The importance of the proteasome and subsequent proteolytic steps in the generation of antigenic peptides. Mol Immunol 39:147–64.
43. A.V.Gomes (2013). Genetics of proteasome diseases. Scientifica 2013, 30 pages. Available from: http://www.hindawi.com.libproxy1.usc.edu/journals/scientifica/2013/637629/cta/
44. T.A.Griffin, D.Nandi, M.Cruz,. (1998). Immunoproteasome assembly: cooperative incorporation of interferon gamma (IFN-gamma)-inducible subunits. J Exp Med 187:97–104.
45. S.Grimm, C.Ott, M.Hörlacher,. (2012). Advanced-glycation-end-product-induced formation of immunoproteasomes: involvement of RAGE and Jak2/STAT1. Biochem J 448:127–39.
46. M.Groettrup, R.Kraft, S.Kostka,. (1996). A third interferon-gamma-induced subunit exchange in the 20S proteasome. Eur J Immunol 26:863–69.
47. T.Grune, D.Botzen, M.Engels,. (2010). Tau protein degradation is catalyzed by the ATP/ubiquitin-independent 20S proteasome under normal cell conditions. Arch Biochem Biophys 500:181–8.
48. T.Grune, B.Catalgol, A.Licht,. (2011). HSP70 mediates dissociation and reassociation of the 26S proteasome during adaptation to oxidative stress. Free Radic Biol Med 51:1355–64.
49. T.Grune, T.Jung, K.Merker, K.J.Davies (2004). Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and ‘aggresomes’ during oxidative stress, aging, and disease. Int J Biochem Cell Biol 36:2519–30.
50. Z.C.Gu, C.Enenkel (2014). Proteasome assembly. Cell Mol Life Sci 71:4729–45.
51. B.Guillaume, J.Chapiro, V.Stroobant,. (2010). Two abundant proteasome subtypes that uniquely process some antigens presented by HLA class I molecules. Proc Natl Acad Sci USA 107:18599–604.
52. J.Hardy, D.J.Selkoe (2002). The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297:353–6.
53. M.Hayashi, T.Ishibashi, K.Tanaka, M.Kasahara (1997). The mouse genes encoding the third pair of beta-type proteasome subunits regulated reciprocally by IFN-gamma: structural comparison, chromosomal localization, and analysis of the promoter. J Immunol 159:2760–70.
54. T.Hayashi, A.Horiuchi, K.Sano,. (2011). Molecular approach to uterine leiomyosarcoma: LMP2-deficient mice as an animal model of spontaneous uterine leiomyosarcoma. Sarcoma 2011, Article ID 476498, 6 pages.
55. S.Heink, D.Ludwig, P.M.Kloetzel, E.Krüger (2005). IFN-γ-induced immune adaptation of the proteasome system is an accelerated and transient response. Proc Natl Acad Sci USA 102:9241–6.
56. K.B.Hendil, S.Khan, K.Tanaka (1998). Simultaneous binding of PA28 and PA700 activators to 20 S proteasomes. Biochem J 332:749–54.
57. E.M.Huber, M.Basler, R.Schwab,. (2012). Immuno- and constitutive proteasome crystal structures reveal differences in substrate and inhibitor specificity. Cell 148:727–38.
58. A.D.Husom, E.A.Peters, E.A.Kolling,. (2004). Altered proteasome function and subunit composition in aged muscle. Arch Biochem Biophys 421:67–76.
59. S.A.Hussong, R.J.Kapphahn, S.L.Phillips,. (2010). Immunoproteasome deficiency alters retinal proteasome’s response to stress. J Neurochem 113:1481–90.
60. A.H.Jansen, E.A.Reits, E.M.Hol (2014). The ubiquitin proteasome system in glia and its role in neurodegenerative diseases. Front Mol Neurosci 7:73.
61. T.Jung, A.Höhn, T.Grune (2014). The proteasome and the degradation of oxidized proteins: part II – protein oxidation and proteasomal degradation. Redox Biol 2:99–104.
62. C.M.Karch, A.M.Goate (2015). Alzheimer’s disease risk genes and mechanisms of disease pathogenesis. Biol Psychiatry 77:43–51.
63. M.Kästle, S.Reeg, A.Rogowska-Wrzesinska, T.Grune (2012). Chaperones, but not oxidized proteins, are ubiquitinated after oxidative stress. Free Radic Biol Med 53:1468–77.
64. S.Keck, R.Nitsch, T.Grune, O.Ullrich (2003). Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer’s disease. J Neurochem 85:115–22.
65. M.A.Khan, H.Oubrahim, E.R.Stadtman (2004). Inhibition of apoptosis in acute promyelocytic leukemia cells leads to increases in levels of oxidized protein and LMP2 immunoproteasome. Proc Natl Acad Sci USA 101:11560–5.
66. A.Kitamura, Y.Maekawa, H.Uehara,. (2011). A mutation in the immunoproteasome subunit PSMB8 causes autoinflammation and lipodystrophy in humans. J Clin Investig 121:4150–60.
67. A.Kniepert, M.Groettrup (2014). The unique functions of tissue-specific proteasomes. Trends Biochem Sci 39:17–24.
68. S.Kotamraju, S.Kalivendi, T.Shang, B.Kalyanaraman (2005). Nitric oxide, proteasomal function, and iron homeostasis-implications in aging and neurodegenerative diseases. Meth Enzymol 396:526–34.
69. S.Kotamraju, S.Matalon, T.Matsunaga,. (2006). Upregulation of immunoproteasomes by nitric oxide: potential antioxidative mechanism in endothelial cells. Free Rad Biol Med 40:1034–44.
70. S.Kotamraju, Y.Tampo, A.Keszler,. (2003). Nitric oxide inhibits H2O2-induced transferrin receptor-dependent apoptosis in endothelial cells: role of ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 100:10653–8.
71. E.Krüger, P.M.Kloetzel (2012). Immunoproteasomes at the interface of innate and adaptive immune responses: two faces of one enzyme. Curr Opin Immunol 24:77–83.
72. É.Le Bourg (2007). Hormetic effects on longevity of hydrogen peroxide in Drosophila melanogaster flies living on a poorly nutritious medium. Biogerontology 8:327–44.
73. E.Leroy, R.Boyer, G.Auburger,. (1998). The ubiquitin pathway in Parkinson’s disease. Nature 395:451–2.
74. Y.Liu, Y.Ramot, A.Torrelo,. (2012). Mutations in proteasome subunit β type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity. Arthritis Rheum 64:895–907.
75. A.Lloret, M.C.Badia, E.Giraldo,. (2011). Amyloid-β toxicity and tau hyperphosphorylation are linked via RCAN1 in Alzheimer’s disease. J Alzheimers Dis 27:701–9.
76. C.J.Lowenstein, E.Padalko (2004). iNOS (NOS2) at a glance. J Cell Sci 117:2865–7.
77. X.Ma, C.Yang, R.Tang,. (2015). Association between LMP2 and LMP7 gene polymorphisms and the risk of gastric cancer: a case-control study. Oncol Lett 10:509–17.
78. W.P.Maksymowych, M.Suarez-Almazor, C.T.Chou, A.Russell (1995). Polymorphism in the LMP2 gene influences susceptibility to extraspinal disease in HLA-B27 positive individuals with ankylosing spondylitis. Ann Rheum Dis 54:321–4.
79. M.K.Mccarthy, J.B.Weinberg (2015). The immunoproteasome and viral infection: a complex regulator of inflammation. Front Microbiol 6, 21 pages.
80. F.Meissner, K.Molawi, A.Zychlinsky (2010). Mutant superoxide dismutase 1-induced IL-1beta accelerates ALS pathogenesis. Proc Natl Acad Sci USA 107:13046–50.
81. M.Mishto, E.Bellavista, A.Santoro,. (2006). Immunoproteasome and LMP2 polymorphism in aged and Alzheimer’s disease brains. Neurobiol Aging 27:54–66.
82. M.J.Morgan, Z.G.Liu (2011). Crosstalk of reactive oxygen species and NF-κB signaling. Cell Res 21:103–15.
83. T.Muchamuel, M.Basler, M.A.Aujay,. (2009). A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis. Nat Med 15:781–7.
84. K.M.Neuman, E.Molina-Campos, T.F.Musial,. (2015). Evidence for Alzheimer’s disease-linked synapse loss and compensation in mouse and human hippocampal CA1 pyramidal neurons. Brain Struct Funct 220:3143–65.
85. V.Ortiz-Navarrete, A.Seelig, M.Gernold,. (1991). Subunit of the ‘20S’ proteasome (multicatalytic proteinase) encoded by the major histocompatibility complex. Nature 353:662–4.
86. P.Pacher, J.S.Beckman, L.Liaudet (2007). Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87:315–424.
87. R.Pacifici, Y.Kono, K.J.A.Davies (1993). Hydrophobicity as the signal for selective degradation of hydroxyl radical-modified hemoglobin by the multicatalytic proteinase complex, proteasome. J Biol Chem 268:15405–11.
88. R.E.Pacifici, D.C.Salo, K.J.A.Davies (1989). Macroxyproteinase (MOP): a 670 kDa proteinase complex that degrades oxidatively denatured proteins in red blood cells. Free Rad Biol Med 7:521–36.
89. M.Pearl-Yafe, D.Halperin, A.Halevy,. (2003). An oxidative mechanism of interferon induced priming of the Fas pathway in Fanconi anemia cells. Biochem Pharmacol 65:833–42.
90. A.Pickering, A.Koop, C.Teoh,. (2010). The immunoproteasome, the 20S proteasome and the PA28alphabeta proteasome regulator are oxidative-stress-adaptive proteolytic complexes. Biochem J 432:585–94.
91. A.M.Pickering, K.J.A.Davies (2012a). Degradation of damaged proteins: the main function of the 20S proteasome. Prog Mol Biol Transl Sci 109:227–48.
92. A.M.Pickering, K.J.A.Davies (2012b). Differential roles of proteasome and immunoproteasome regulators Pa28αβ, Pa28γ and Pa200 in the degradation of oxidized proteins. Arch Biochem Biophys 523:181–90.
93. A.M.Pickering, M.Lehr, R.A.Miller (2015). Lifespan of mice and primates correlates with immunoproteasome expression. J Clin Investig 125:2059–68.
94. A.M.Pickering, R.A.Linder, H.Zhang,. (2012). Nrf2-dependent induction of proteasome and Pa28αβ regulator are required for adaptation to oxidative stress. J Biol Chem 287:10021–31.
95. A.M.Pickering, T.A.Staab, J.Tower,. (2013a). A conserved role for the 20S proteasome and Nrf2 transcription factor in oxidative stress adaptation in mammals, Caenorhabditis elegans and Drosophila melanogaster. J Exp Biol 216:543–53.
96. A.M.Pickering, L.Vojtovich, J.Tower, K.DAVIESKJA. (2013b). Oxidative stress adaptation with acute, chronic, and repeated stress. Free Radic Biol Med 55:109–18.
97. R.Planas, J.Carrillo, A.Sanchez,. (2010). Gene expression profiles for the human pancreas and purified islets in Type 1 diabetes: new findings at clinical onset and in long-standing diabetes. Clin Exp Immunol 159:23–44.
98. D.Poppek, S.Keck, G.Ermak,. (2006). Phosphorylation inhibits turnover of the tau protein by the proteasome: influence of RCAN1 and oxidative stress. Biochem J 400:511–20.
99. S.R.Powell, P.Wang, A.Divald,. (2005). Aggregates of oxidized proteins (lipofuscin) induce apoptosis through proteasome inhibition and dysregulation of proapoptotic proteins. Free Rad Biol Med 38:1093–101.
100. K.Puttaparthi, J.L.Elliott (2005). Non-neuronal induction of immunoproteasome subunits in an ALS model: possible mediation by cytokines. Exp Neurol 196:441–51.
101. T.Reinheckel, N.Sitte, O.Ullrich,. (1998). Comparative resistance of the 20S and 26S proteasome to oxidative stress. Biochem J 335:637–42.
102. A.J.Rivett, S.Bose, P.Brooks, K.I.Broadfoot (2001). Regulation of proteasome complexes by γ-interferon and phosphorylation. Biochimie 83:363–6.
103. C.E.Rockwell, J.J.Monaco, N.Qureshi (2012). A critical role for the inducible proteasomal subunits LMP7 and MECL1 in cytokine production by activated murine splenocytes. Pharmacology 89:117–26.
104. K.B.Schwarz (1996). Oxidative stress during viral infection: a review. Free Radic Biol Med 21:641–9.
105. U.Seifert, L.P.Bialy, F.Ebstein,. (2010). Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress. Cell 142:613–24.
106. H.M.Semchyshyn (2014). Hormetic concentrations of hydrogen peroxide but not ethanol induce cross-adaptation to different stresses in budding yeast. Int J Microbiol 2014, Article ID 485792, 5 pages.
107. F.Shang, A.Taylor (1995). Oxidative stress and recovery from oxidative stress are associated with altered ubiquitin conjugating and proteolytic activities in bovine lens epithelial cells. Biochem J 307:297–303.
108. R.Shringarpure, T.Grune, J.Mehlhase, K.J.Davies (2003). Ubiquitin conjugation is not required for the degradation of oxidized proteins by proteasome. J Biol Chem 278:311–18.
109. N.Sitte, M.Huber, T.Grune,. (2000a). Proteasome inhibition by lipofuscin/ceroid during postmitotic aging of fibroblasts. FASEB J 14:1490–8.
110. N.Sitte, K.Merker, T.von Zglinicki,. (2000b). Protein oxidation and degradation during cellular senescence of human BJ fibroblasts: part II—aging of nondividing cells. FASEB J 14:2503–10.
111. N.Sitte, K.Merker, T.von Zglinicki,. (2000c). Protein oxidation and degradation during cellular senescence of human BJ fibroblasts: part I—effects of proliferative senescence. FASEB J 14:2495–502.
112. E.R.Stadtman (2006). Protein oxidation and aging. Free Rad Res 40:1250–8.
113. F.L.Stratford, N.Chondrogianni, I.P.Trougakos,. (2006). Proteasome response to interferon-gamma is altered in senescent human fibroblasts. FEBS Lett 580:3989–94.
114. Y.Takada, A.Mukhopadhyay, G.C.Kundu,. (2003). Hydrogen peroxide activates NF-κB through tyrosine phosphorylation of IκBα and serine phosphorylation of p65 evidence for the involvement of IκBα kinase and Syk protein-tyrosine kinase. J Biol Chem 278:24233–41.
115. N.Tanahashi, Y.Murakami, Y.Minami,. (2000). Hybrid proteasomes: induction by interferon-γ and contribution to ATP-dependent proteolysis. J Biol Chem 275:14336–45.
116. K.Tanoka, M.Kasahara (1998). The MHC class I ligand‐generating system: roles of immunoproteasomes and the interferon‐4gMY‐inducible proteasome activator PA28. Immunol Rev 163:161–76.
117. C.Y.Teoh, K.J.A.Davies (2004). Potential roles of protein oxidation and the immunoproteasome in MHC class I antigen presentation: the ‘PrOxI’ hypothesis. Arch Biochem Biophys 423:88–96.
118. S.Thomas, S.Kotamraju, J.Zielonka,. (2007). Hydrogen peroxide induces nitric oxide and proteosome activity in endothelial cells: a bell-shaped signaling response. Free Rad Biol Med 42:1049–61.
119. D.Vilchez, I.Saez, A.Dillin (2014). The role of protein clearance mechanisms in organismal ageing and age-related diseases. Nat Commun 5.
120. M.P.Vitek, K.Bhattacharya, J.M.Glendening,. (1994). Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc Natl Acad Sci USA 91:4766–70.
121. X.Wang, J.Yen, P.Kaiser, L.Huang (2010). Regulation of the 26S proteasome complex during oxidative stress. Sci Signal 3:ra88.
122. Y.Watanabe, O.Suzuki, T.Haruyama, T.Akaike (2003). Interferon‐γ induces reactive oxygen species and endoplasmic reticulum stress at the hepatic apoptosis. J Cell Biochem 89:244–53.
123. K.Whalley (2015). Neurodegenerative disease: restoring balance in Huntington disease. Nat Rev Neurosci 16:66–7.
124. Z.Yu, Q.Liu, C.Huang,. (2013). The interleukin 10-819C/T polymorphism and cancer risk: a HuGE review and meta-analysis of 73 studies including 15,942 cases and 22,336 controls. Omics 17:200–14.
125. Y.S.Yun, K.H.Kim, B.Tschida,. (2016). mTORC1 coordinates protein synthesis and immunoproteasome formation via PRAS40 to prevent accumulation of protein stress. Mol Cell 61:625–39.
126. P.Zhou, H.Cao, M.Smart, C.David (1993). Molecular basis of genetic polymorphism in major histocompatibility complex-linked proteasome gene (Lmp-2). Proc Natl Acad Sci USA 90:2681–4.